Bladder cancer trials in Germany
10 of 38 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRegistry Platform Urologic Cancer
- Where
- Multiple Locations
- Age
- 18 years and over
- People
- 2,230
- Run by
- iOMEDICO AG
See details and how to joinNCT03374267 - No phaseTaking peopleExploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
- Where
- Hamburg, Herne, München, Ulm
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Photocure
See details and how to joinNCT07144319 - No phaseTaking peoplePeripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as Perioperative Systemic Therapy for Urothelial Carcinoma
- Where
- Munich
- Age
- 18 years and over
- People
- 79
- Run by
- Comprehensive Cancer Center Munich (CCCM)
See details and how to joinNCT07870577 - No phaseTaking peoplePerioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS)
- Where
- Munich
- Age
- 18 years and over
- People
- 500
- Run by
- LMU Klinikum
See details and how to joinNCT07855926 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Hamburg, Heilbronn, Munich
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Tübingen
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peoplePeripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma
- Where
- Augsburg, Munich, Würzburg
- Age
- 18 years and over
- People
- 80
- Run by
- Comprehensive Cancer Center Munich (CCCM)
See details and how to joinNCT06657157 - No phaseNot yet taking people in GermanyStudy on Risk Assessment for Patients With Microscopic Hematuria (Non-Visible Blood in Urine) Using a Urine Marker Test
- Where
- Ulm
- Age
- 40 years and over
- People
- 1,475
- Run by
- Christian Bolenz
See details and how to joinNCT07307300 - No phaseTaking peopleClinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
- Where
- Erlangen
- Age
- 18 years and over
- People
- 200
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT04892849 - No phaseTaking peopleOnline Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
- Where
- Berlin
- Age
- 18 years and over
- People
- 649
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT06116019